Neogenomics Inc.
12701 Common Wealth Drive
Suite 9
Fort Myers,
FL 33913
United States - Map
Phone: 239-768-0600
Fax: 239-768-0711
Web Site: http://www.neogenomics.org
| NeoGenomics, Inc., doing business as NeoGenomics Laboratories, operates a network of cancer-focused testing laboratories in the United States. The company provides various testing services, including cytogenetics testing, which analyzes human chromosomes; Fluorescence In-Situ Hybridization testing that analyzes abnormalities at the chromosomal and gene levels; flow cytometry testing, which analyzes gene expression of specific markers inside cells and on cell surfaces; immunohistochemistry testing that analyzes the distribution of tumor antigens in specific cell and tissue types; and molecular testing, which involves in the analysis of DNA and RNA to diagnose and predict the clinical significance of various genetic sequence disorders. It offers these testing services for the diagnosis, prognosis, and prediction for response to the therapy of various cancers. The company markets clinical diagnostic services to pathologists, oncologists, urologists, hospitals, and other laboratories. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Robert P. Gasparini M.S., 55
Pres, Chief Science Officer |
$
270.00K | N/A | Dr. Michael T. Dent M.D., 45
Founder, Director and Member of Compensation Committee |
$
18.00K | N/A | Mr. Steven C. Jones , 47
Exec. VP of Fin., Director of Investor Relations, Director, Member of Audit Committee and Member of Compensation Committee |
$
17.00K | N/A | Mr. Jerome J. Dvonch , 42
Principal Accounting Officer of Fin. |
$
151.00K | N/A | Dr. Robert J. Feeney Ph.D., 42
VP of Bus. Devel. |
$
193.00K | N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.31% Nasdaq 0.00%
Profile
